Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer-Reference-Cited by-同舟云学术

Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer

Published:2019-06-20 Issue:2 Volume:177 Page:335-343
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Isnaldi Edoardo,Ferraioli Domenico,Ferrando Lorenzo,Brohée Sylvain,Ferrando Fabio,Fregatti Piero,Bedognetti Davide,Ballestrero Alberto,Zoppoli Gabriele^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05313-w.pdf

Reference49 articles.

1. Ferlay J, Soerjomataram I, Dikshit RES, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210

2. Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752. https://doi.org/10.1038/35021093

3. Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360:790–800. https://doi.org/10.1056/NEJMra0801289

4. Hart CD, Sanna G, Siclari O, Biganzoli L, Di Leo A (2015) Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes. Breast 24(Suppl 2):S136–S142. https://doi.org/10.1016/j.breast.2015.07.033

5. Barretina J, Caponigro G, Stransky N et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603–607. https://doi.org/10.1038/nature11003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer;Cancer Treatment Reviews;2024-07

2. Signaling by Type I Interferons in Immune Cells: Disease Consequences;Cancers;2024-04-22

3. Modulation of SLFN11 induces changes in DNA Damage response in breast cancer;Cancer Cell International;2023-11-24

4. Adaptive Sparse Multi-Block PLS Discriminant Analysis: An Integrative Method for Identifying Key Biomarkers from Multi-Omics Data;Genes;2023-04-23

5. Modulation of SLFN11 induces changes in DNA Damage response;2023-04-03